GRINL1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.476000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.503600E-01
Normal-vs-Stage2
4.572200E-01
Normal-vs-Stage3
9.778000E-02
Normal-vs-Stage4
9.715800E-01
Stage1-vs-Stage2
2.542800E-01
Stage1-vs-Stage3
5.771700E-02
Stage1-vs-Stage4
9.122400E-01
Stage2-vs-Stage3
1.762210E-01
Stage2-vs-Stage4
4.204200E-01
Stage3-vs-Stage4
8.790000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.289000E-01
Normal-vs-AfricanAmerican
8.040600E-01
Normal-vs-Asian
2.306200E-01
Caucasian-vs-AfricanAmerican
5.441400E-01
Caucasian-vs-Asian
2.048600E-01
AfricanAmerican-vs-Asian
2.678000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.747200E-01
Normal-vs-Female
4.234000E-01
Male-vs-Female
7.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.255600E-01
Normal-vs-Age(41-60Yrs)
7.600800E-01
Normal-vs-Age(61-80Yrs)
3.423400E-01
Normal-vs-Age(81-100Yrs)
3.126400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.590000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.412200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.769200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.920290E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.911380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.808600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.003600E-01
Normal-vs-Daily Drinker
1.177850E-01
Normal-vs-Weekly Drinker
2.420600E-01
Normal-vs-Occasional Drinker
7.031400E-01
Normal-vs-Social Drinker
5.470400E-01
Non Drinker-vs-Daily Drinker
4.946000E-01
Non Drinker-vs-Weekly Drinker
8.181800E-01
Non Drinker-vs-Occasional Drinker
2.870600E-01
Non Drinker-vs-Social Drinker
3.261400E-01
Daily Drinker-vs-Weekly Drinker
7.511800E-01
Daily Drinker-vs-Occasional Drinker
1.208230E-01
Daily Drinker-vs-Social Drinker
1.485750E-01
Weekly Drinker-vs-Occasional Drinker
2.972800E-01
Weekly Drinker-vs-Social Drinker
3.463800E-01
Occasional Drinker-vs-Social Drinker
8.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.219400E-01
Normal-vs-Grade 2
7.506400E-01
Normal-vs-Grade 3
7.273400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.639000E-01
Grade 1-vs-Grade 3
2.129600E-01
Grade 1-vs-Grade 4
8.219400E-01
Grade 2-vs-Grade 3
6.415000E-01
Grade 2-vs-Grade 4
7.506400E-01
Grade 3-vs-Grade 4
7.273400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.344400E-01
Normal-vs-NonDiabetic
3.997200E-01
Diabetic-vs-NonDiabetic
4.541600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.934300E-02
Normal-vs-NoPancreatitis
4.162800E-01
Pancreatitis-vs-NoPancreatitis
2.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.095000E-01
Normal-vs-N1
4.917800E-01
N0-vs-N1
5.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.259800E-01
Normal-vs-TP53-NonMutant
6.419800E-01
TP53-Mutant-vs-TP53-NonMutant
4.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
